Table 1.
Compound | Evidence | Notes | Reference(s) |
---|---|---|---|
Nε-carboxymethyl-lysine (CML) | Strongly retained inside Caco-2 cells. | Diffused into gastrointestinal epithelial (Caco-2) cells, but was not able to cross the basolateral membrane. Accumulation in intestinal cells. Not likely transported by amino acid and peptide carriers and the transepithelial flux measured for the compounds occurs most probably by simple diffusion. |
[34,35] |
Nε-carboxyethyl-lysine (CEL) | Strongly retained inside Caco-2 cells. | - | [34] |
methylglyoxal-derived hydroimidazolone-1 (MG-H1) | Strongly retained inside Caco-2 cells. | - | [34] |
Maltosine | Absorbed as dipeptide into Caco-2 cells by PEPT1 and strongly retained in cells. Not absorbed in free form. |
Free maltosine permeates the basolateral cell membrane by simple diffusion down its concentration gradient and possibly by the action of basolateral amino acid transporters. | [34,36] |
Glycated dipeptides | Absorbed into Caco-2 cells by PEPT1. | Intracellularly hydrolysed by peptidases to the free modified amino acids and alanine. | [34] |
Pyrraline | Not free pyrraline, but the dipeptide with alanine is absorbed by PEPT1 in HeLa cells (cervical cancer cells). | After intracellular hydrolysation free pyrraline diffused through the basolateral membrane. | [34,37] |
fructoselysine | Simple diffusion to a small extent in Caco-2 cells. | Not likely transported by amino acid and peptide carriers and the transepithelial flux measured for the compounds occurs most probably by simple diffusion. | [35] |